Atazanavir Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 150 mg, 200 mg, 300 mg
Reference Brands: Reyataz®(EU & US)
Category: Anti Viral
Atazanavir Capsules (150–300 mg), sold under brands like Reyataz® and Atavir®, are protease inhibitors for HIV-1 treatment. Widely used in combination therapy, they’re available for bulk procurement on PharmaB2B platforms from WHO-GMP suppliers—ideal for tenders, NGOs, and HIV programs. Atazanavir is available in Capsules and strengths such as 150 mg, 200 mg, 300 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Atazanavir is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Atazanavir can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Atazanavir Capsules, marketed globally under brands like Reyataz®, Atavir®, and Atazor®, are essential protease inhibitors used in combination antiretroviral therapy (cART) for HIV-1 treatment. Available in 150 mg, 200 mg, and 300 mg strengths, Atazanavir is often co-administered with Ritonavir to boost its effectiveness. With WHO and USFDA endorsements, PharmaB2B platforms enable global sourcing from GMP-certified manufacturers for bulk procurement, tenders, and public health supply chains. This once-daily dosing option is well-tolerated and vital in global HIV management programs. Partner with trusted suppliers to ensure quality and cost-effective access to key antiretroviral medicines.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Atazanavir is an antiretroviral medication used to treat HIV infection. It works by inhibiting the HIV protease enzyme, preventing the virus from maturing and multiplying, thereby helping to control viral load and improve immune function.
Atazanavir is made from a synthetic protease inhibitor compound that targets HIV protease to block viral replication.
A common trade name for Atazanavir is Reyataz.
Reyataz (Atazanavir) is manufactured by Bristol-Myers Squibb, with multiple generic versions produced by other pharmaceutical companies globally.
The generic name is atazanavir.
The brand name is Reyataz, along with other regional generic brands.
Atazanavir is manufactured in multiple regions, including India, the USA, and Europe, by licensed pharmaceutical manufacturers.
Related Products
Maraviroc
Strength:
150 mg, 300 mg, 20 mg
Form: Tablets / Oral solution
Reference Brands: Selzentry (USA), Celsentri (EU)
View DetailsRaltegravir
Strength:
100mg, 400 mg, 600mg
Form: Tablets
Reference Brands: Isentress (USA/EU)
View DetailsQuick Response Guaranteed | Verified Suppliers